Application and Implications of High-Impact Data From the European Hematology Association (EHA) Virtual Congress 2021*

Download All
June 9-17, 2021; Virtual
Learn from international experts how key studies presented at the 2021 EHA virtual meeting will affect managmenet of patients with hematologic malignancies and nonmalignant blood disorders in this commentary and accompanying highlights downloadable slideset.
Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, FMedSci
María-Victoria Mateos, MD, PhD
Lydia Scarfò, MD
Ali T. Taher, MD, PhD, FRCP

ClinicalThought Commentary

Read this commentary where hematology experts from Europe share their thoughts on important results from key clinical trials on β-thalassemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and multiple myeloma presented at the virtual EHA 2021 meeting.

Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, FMedSci María-Victoria Mateos, MD, PhD Lydia Scarfò, MD Ali T. Taher, MD, PhD, FRCP Released: July 28, 2021
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by:
Bristol-Myers Squibb
Jazz Pharmaceuticals

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue